Clinical Trials Logo
  1. Home
  2. Septicemia
  3. NCT03583762

Time to Appropriate Antibiotic Between Using Microarray Assay and Mass Spectrometry Technique

Septicemia Clinical Trial

Official title:
Comparison of Time to Appropriate Antibiotic Between Using Microarray Assay and Mass Spectrometry Technique for Identification of Positive Blood Cultures

Clinical Trial Summary

This is an experimental study of participants who had positive blood culture to compare time to appropriate antibiotic between using Microarray Assay and Mass Spectrometry to bacterial Identification.

Clinical Trial Description

Between June to Dec 2018, 200 participants those met the eligibility criteria were enrolled in this study that is a quasi experimental study. All participants were empirical antibiotic therapy by infectious physician. 100 patients in Pre-intervention group had bacterial identification by Mass spectrometry technique from bacterial colony and 100 patients in Post-intervention group had bacterial identification by Microarray assay from blood culture. Antibiotic adjustment were considered after bacterial identification and result of antibiotic susceptibility testing. Then all participants were re-evaluated outcome after treatment. Finally, the results were ready to analysis in January 2019. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03583762
Study type Interventional
Source Chiang Mai University
Contact Parichart Sakulkonkij, MD
Phone +66-81595-8662
Email papi-jung@hotmail.com
Status Not yet recruiting
Phase N/A
Start date July 30, 2018
Completion date March 31, 2019
View Details
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT04764058 - Efficacy and Safety of Colistin Based Antibiotic Therapy Phase 1/Phase 2
Completed NCT03088865 - Evaluation of an Internal Hospital Practice: The Effect of Altered Test Tubes Sampling Order on Blood Culture Contamination Rates N/A
Completed NCT00046072 - A Safety and Efficacy Study of Intravenous E5564 in Patients With Severe Sepsis Phase 2
Completed NCT01520597 - National Study on Listeriosis and Listeria
Recruiting NCT03929159 - Correlating MicroRNA Changes With Sepsis Outcomes
Completed NCT03943719 - Clinical Impact of the FilmArray Blood Culture Identification Panel Performed on Positive Blood Cultures From Intensive Care Patients With Septicemia
Completed NCT00901940 - Understanding the Immune Response to Meningitis Vaccines Phase 3
Completed NCT02988414 - Diagnosis of Bacteremia/Septicemia and Culture Negative Endocarditis by the Karius Sequencing-Based Infectious Disease Diagnostic Assay
Completed NCT02102087 - Study to Evaluate the Effectiveness of the Initial Specimen Diversion Device N/A
Recruiting NCT05045963 - Impact of Aminoglycosides in Hypotensive Septic Oncology Patients
Terminated NCT02093494 - Study to Evaluate the Effectiveness of the Initial Specimen Diversion Device When Collected Through Peripheral Intravenous Catheters N/A
Active, not recruiting NCT02069028 - Effectiveness of Different Interventions for Implementing Surviving Sepsis Campaign (SSC) Guidelines on Compliance and Mortality: Systematic Review and Meta-analysis N/A
Recruiting NCT00258869 - Observational Study of Sepsis and Pneumonia to Develop Diagnostic Tests N/A
Completed NCT05358912 - Efficacy of Targeted Abdominal Perfusion Pressure in Septic Shock Phase 4
Recruiting NCT05893420 - A Rapid Diagnostic of Risk in Hospitalized Patients Using Machine Learning N/A
Recruiting NCT05040503 - Monitoring Mitophagy In Myeloid Cells Upon Intensive Care N/A
Completed NCT00146432 - Immunoadsorption of LPS, C5a and IL-6 in Severe Sepsis and Septic Shock (ISASS-1) Phase 2/Phase 3
No longer available NCT04636554 - Personalized Phage Treatment in Covid-19 Patients With Bacterial Co-Infections Microbials for Pneumonia or Bacteremia/Septicemia